Alprostadil
"Alprostadil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent vasodilator agent that increases peripheral blood flow.
Descriptor ID |
D000527
|
MeSH Number(s) |
D10.251.355.255.550.250.050 D10.251.355.325.050 D23.469.050.175.725.780.050
|
Concept/Terms |
Alprostadil- Alprostadil
- PGE1
- Prostaglandin E1
- Prostaglandin E1alpha
- Lipo-PGE1
- Lipo PGE1
- PGE1alpha
Edex- Edex
- Viridal
- Prostavasin
- Schwarz Brand of Alprostadil
- Allphar Brand of Alprostadil
- Hoyer Brand of Alprostadil
Prostin VR- Prostin VR
- Astra Brand of Alprostadil
- AstraZeneca Brand of Alprostadil
- Vivus Brand of Alprostadil
- Minprog
- Paladin Brand of Alprostadil
- Pharmacia Brand 1 of Alprostadil
- Prostine VR
- Abbott Brand of Alprostadil
- Janssen Brand of Alprostadil
Vasaprostan- Vasaprostan
- Schwarz Pharma Brand of Alprostadil
Caverject- Caverject
- Sugiran
- Pharmacia Brand 2 of Alprostadil
|
Below are MeSH descriptors whose meaning is more general than "Alprostadil".
Below are MeSH descriptors whose meaning is more specific than "Alprostadil".
This graph shows the total number of publications written about "Alprostadil" by people in this website by year, and whether "Alprostadil" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1984 | 0 | 1 | 1 | 1985 | 0 | 1 | 1 | 1988 | 0 | 1 | 1 | 1990 | 0 | 1 | 1 | 1991 | 1 | 0 | 1 | 1992 | 0 | 1 | 1 | 1993 | 0 | 1 | 1 | 1995 | 0 | 1 | 1 | 1997 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Alprostadil" by people in Profiles.
-
Aly SA, Awad SM, Abdulla RI, Kazmouz S, Nguyen HH. Chronic Low Dose Prostaglandin and Neonatal Heart Block. Pediatr Cardiol. 2017 Oct; 38(7):1515-1518.
-
Cash BD, Chang L, Sabesin SM, Vitat P. Update on the management of adults with chronic idiopathic constipation. J Fam Pract. 2007 Jun; 56(6 Suppl Update):S13-9; quiz S20.
-
Somberg JC, Yelamanchi V, Molnar J, Aschermann M, Bernink PJ, Caspi A, Marmor A, Rabinowitz B, Reisin L, Ruzyllo W. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. Am J Ther. 1997 Nov-Dec; 4(11-12):401-4.
-
Kachur JF, Keshavarzian A, Sundaresan R, Doria M, Walsh R, de las Alas MM, Gaginella TS. Colitis reduces short-circuit current response to inflammatory mediators in rat colonic mucosa. Inflammation. 1995 Apr; 19(2):245-59.
-
Cook EH, Arora RC, Anderson GM, Berry-Kravis EM, Yan SY, Yeoh HC, Sklena PJ, Charak DA, Leventhal BL. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci. 1993; 52(25):2005-15.
-
Berry-Kravis E, Huttenlocher PR. Cyclic AMP metabolism in fragile X syndrome. Ann Neurol. 1992 Jan; 31(1):22-6.
-
Gerber GS, Levine LA. Pharmacological erection program using prostaglandin E1. J Urol. 1991 Sep; 146(3):786-9.
-
Keshavarzian A, Haydek JM, Zepeda DO, Stinneford JG, Fields JZ. Gastroduodenal ulcers in rats induced by 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): requirement for gastric acid secretion and the role of prostaglandins. Res Commun Chem Pathol Pharmacol. 1990 Oct; 70(1):21-48.
-
Berry-Kravis E, Kazmierczak BI, Derechin V, Dawson G. Neuromodulator-mediated phosphorylation of specific proteins in a neurotumor hybrid cell line (NCB-20). J Neurochem. 1988 Apr; 50(4):1287-96.
-
Berry-Kravis E, Dawson G. Evidence for [D-Ala2,D-Leu5]enkephalin-induced supersensitivity to 5-hydroxytryptamine in a neurotumor x brain hybrid cell line (NCB-20). J Neurochem. 1985 Dec; 45(6):1731-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|